欢迎访问《解剖学报》官方网站!今天是 English
细胞和分子生物学

破骨细胞释放凋亡小体微小RNA-30a对成骨活性的影响

  • 符义亮 ,
  • 袁凤来
展开
  • 1. 安徽省庐江县人民医院骨科, 安徽 庐江 231500; 2. 江南大学附属医院中西医结合研究所,江苏 无锡 214041

收稿日期: 2020-04-01

  修回日期: 2020-06-12

  网络出版日期: 2021-08-06

基金资助

江苏省自然科学基金

Effect of osteoclast-derived apoptotic body microR-30a on osteogenic activity

  • FU Yi-Liang ,
  • YUAN Feng-Lai
Expand
  • 1.Orthopaedics Department, People’s Hospital of Lujiang County,  Anhui Lujiang 231500, China; 2.Institute of Integrated Chinese and Western Medicine, the Affiliated Hospital of Jiangnan University, Jiangsu Wuxi 214041, China

Received date: 2020-04-01

  Revised date: 2020-06-12

  Online published: 2021-08-06

摘要

目的  探讨破骨细胞凋亡释放凋亡小体介导成骨活性的作用。   方法 通过小鼠(n=10)骨髓单核细胞体外诱导破骨细胞,用抗酒石酸酸性磷酸酶(TRAP)染色和细胞骨架F-actin与DAPI双标免疫荧光鉴定破骨细胞,破骨细胞与小鼠成骨细胞MC-3T3E1共培养体系,DNA片段化ELISA分析破骨细胞凋亡,凋亡小体标志物检测,骨形成标志物Real-time PCR分析,凋亡小体微小RNA (miRNA)表达谱芯片筛查。   结果  100 μmol/L 阿伦膦酸钠(ALN) 诱导成熟破骨细胞凋亡,并释放凋亡小体;Western blotting检测表明,ALN诱导凋亡小体特异性表面标志物蛋白表达增强;破骨细胞凋亡小体蛋白C3b表达增高与成骨细胞活性负相关;凋亡小体表达谱芯片筛查提示,miR-30a与骨形成标志物血清碱性磷酸酶(ALP)相关。   结论  破骨细胞凋亡释放的凋亡小体携带miR-30a抑制成骨细胞活性,凋亡小体可能参与破骨细胞与成骨细胞的对话。

本文引用格式

符义亮 , 袁凤来 . 破骨细胞释放凋亡小体微小RNA-30a对成骨活性的影响[J]. 解剖学报, 2021 , 52(4) : 561 -566 . DOI: 10.16098/j.issn.0529-1356.2021.04.010

Abstract

Objective  To explore that whether apoptotic bodies released by osteoclasts mediate osteogenic activity.    Methods  The osteoclasts were induced from mouse(n=10)bone marrow monocytes in vitro, and were identified by tartrate resistant acid phosphatase (TRAP) staining, F-actin, and DAPI double labeling immunofluorescence. The Co-culture system of osteoclasts and mouse osteoblasts MC-3T3E1 was established. The apoptosis of osteoclasts was analyzed by DNA fragment ELISA. Immunoblotting of apoptotic body markers was investigated. Real-time PCR analysis of bone formation markers was tested. MiRNA expression profiling of apoptotic body was identisfied.    Results  Alendronate (ALN) 100 μmol/L induced osteoclast apoptosis and caused apoptotic body release from osteoclasts. The expression of C3b and annexin Ⅴ protein was enhanced by ALN; the expression of C3b in osteoclasts was negatively correlated with the activity of osteoblasts; the microarray screening of apoptotic body showed that miR-30a was correlated with bone formation markers and serum alkaline phosphatase (ALP).    Conclusion  Osteoclast-derived apoptotic body miR-30a can inhibit the activity of osteoblasts. Apoptotic body may participate in the dialogue between osteoclasts and osteoblasts.

参考文献

[1] Sleeman A, Clements JN. Abaloparatide: a new pharmacological option for osteoporosis[J]. Am J Health Syst Pharm, 2019, 76(3): 130-135.
[2] Kalyanaraman H, Ramdani G, Joshua J, et al. A novel, direct NO donor regulates osteoblast and osteoclast functions and increases bone mass in ovariectomized mice[J]. J Bone Miner Res, 2017, 32(1): 46-59.
[3] Yuan FL, Ye JX, Wang HJ, et al. Effect of Yishen Mic Gu Recipe on bone coversion index betwa-CTX in patients with kidney deficiency osteoporosis[J/OL]. Journal of Clinical Medical Literature, 2017, 4(9): 17825-17827. (in Chinese)
袁凤来, 叶俊星, 王昊珏, 等. 益肾密骨方对肾虚型骨质疏松症患者骨转换指标β-CTX的影响[J/OL]. 临床医药文献电子杂志,2017,4(91): 17825-17827.
[4] Cao X. Targeting osteoclast-osteoblast communication[J]. Nat Med, 2011, 17(11): 1344-1346.
[5] Yuan FL, Ye JX, Li X. Effect of invigorating kidney and sealing bone recipe on bone formation in patients with kidney deficiency osteoporosis[J]. Chinese Journal of Osteoporosis, 2019, 25(8): 1163-1165, 1711. (in Chinese)
袁凤来, 叶俊星, 李霞. 益肾密骨方对肾虚型骨质疏松症患者骨形成的影响[J]. 中国骨质疏松杂志, 2019, 25(8): 1163-1165, 1171. 
[6] Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice[J]. Mayo Clin Proc, 2008, 83(9): 1032-1045.
[7] Tao H, Yang HY, Yu MCh, et al. Effects of systemic transplantation of allograft adipose-derived stem cells in glucocorticoid-induced osteoporosis rats[J]. Acta Anatomica Sinica, 2011, 42(20): 220-225. (in Chinese)
陶晖, 杨会营, 余美春, 等. 异体脂肪源干细胞移植对糖皮质激素性骨质疏松大鼠的影响[J]. 解剖学报, 2011, 42(2): 220-225. 
[8] Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation[J]. Nature, 2003, 423(6937): 337-342.
[9] Li C, Yang Z, Li Z, et al. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways[J]. J Bone Miner Res, 2011, 26(3): 644-656.
[10] Yuan FL, Xu RS, Ye JX, et al. Apoptotic bodies from endplate chondrocytes enhance the oxidative stress-induced mineralization by regulating PPi metabolism[J]. J Cell Mol Med, 2019, 23(5): 3665-3675.
[11] Liu D, Kou X, Chen C, et al. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors[J]. Cell Res, 2018, 28(9): 918-933.
[12] Negishi-Koga T, Shinohara M, Komatsu N, et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D[J]. Nat Med, 2011, 17(11): 1473-1480.
[13] Sun W, Zhao C, Li Y, et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity[J]. Cell Discov, 2016, 2: 16015.
[14] Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation[J]. Nat Commun, 2016, 7: 10872.
[15] Barreca MM, Aliotta E, Geraci F. Extracellular vesicles in multiple sclerosis as possible biomarkers: dream or reality[J]. Adv Exp Med Biol, 2017, 958(1): 1-9.
[16] Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection[J]. Sci Signal, 2009, 2(100): ra81.
[17] Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function[J]. Trends Biochem Sci, 2012, 37(11): 460-465.
文章导航

/